The CoughRetrain Program: Restoring Control Through a Non-pharmacological Intervention

PURPOSE: Non-pharmacological cough interventions are recommended for refractory chronic cough (RCC), yet structured development processes and integration of behavioral theory are rarely described. We report on the development and feasibility of CoughRetrain, a theory-informed telehealth behavioral program that integrates behavior-change strategies to support voluntary control of coughing in RCC. METHODS: CoughRetrain was developed following Medical Research Council guidance through staged problem identification, evidence review, multidisciplinary refinement, remote adaptation, and formative testing in interstitial lung disease. The final five-session individual program integrates education, graded suppression practice, motivational interviewing, and goal setting. A single-group feasibility pilot in adults with RCC assessed adherence, fidelity, adverse events, general self-efficacy (New General Self-Efficacy Scale), cough-specific self-efficacy (Cough-Specific Self-Efficacy Scale), cough-related quality of life [Leicester Cough Questionnaire (LCQ)], cough severity visual analogue scale (CS-VAS), and 24-hour objective cough frequency. RESULTS: Twelve participants were enrolled, and eleven (median age 51 [38-63] years; 55% female; median cough duration 6 [3-20] years) completed the program. All core components were delivered. Two non-serious adverse events occurred (urticaria; headache). General self-efficacy remained stable (mean change 0.04 ± 0.19). Cough-specific self-efficacy increased by 0.3 ± 0.6. LCQ increased by 3.6 ± 3.0 points (95%CI 1.5 to 5.6). CS-VAS decreased by 18.8 ± 25.0 mm (95%CI -35.7 to -1.9), and 24-hour cough frequency decreased by 48% (95%CI -74% to +3%). CONCLUSIONS: CoughRetrain is a safe and feasible telehealth intervention for RCC developed through a transparent, patient-informed process. Preliminary findings align with behavioral cough literature. Larger controlled studies evaluating long-term efficacy are warranted.

Authors

Institutions

Publication Details

Journal
Lung
Published
2026-05-28
DOI
https://doi.org/10.1007/s00408-026-00899-7
Primary Topic
Respiratory and Cough-Related Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The CoughRetrain Program: Restoring Control Through a Non-pharmacological Intervention

Ana Oliveira, Elena Kum, Renata Mancopes, D Brooks et al.
Lung
Respiratory and Cough-Related Research
article

The CoughRetrain Program: Restoring Control Through a Non-pharmacological Intervention

Ana Oliveira, Elena Kum, Renata Mancopes, D Brooks, Shirley Quach, Mustafaa Wahab, Imran Satia, Anastasia N.L. Newman, Kim Smith
article en

Abstract

PURPOSE: Non-pharmacological cough interventions are recommended for refractory chronic cough (RCC), yet structured development processes and integration of behavioral theory are rarely described. We report on the development and feasibility of CoughRetrain, a theory-informed telehealth behavioral program that integrates behavior-change strategies to support voluntary control of coughing in RCC. METHODS: CoughRetrain was developed following Medical Research Council guidance through staged problem identification, evidence review, multidisciplinary refinement, remote adaptation, and formative testing in interstitial lung disease. The final five-session individual program integrates education, graded suppression practice, motivational interviewing, and goal setting. A single-group feasibility pilot in adults with RCC assessed adherence, fidelity, adverse events, general self-efficacy (New General Self-Efficacy Scale), cough-specific self-efficacy (Cough-Specific Self-Efficacy Scale), cough-related quality of life [Leicester Cough Questionnaire (LCQ)], cough severity visual analogue scale (CS-VAS), and 24-hour objective cough frequency. RESULTS: Twelve participants were enrolled, and eleven (median age 51 [38-63] years; 55% female; median cough duration 6 [3-20] years) completed the program. All core components were delivered. Two non-serious adverse events occurred (urticaria; headache). General self-efficacy remained stable (mean change 0.04 ± 0.19). Cough-specific self-efficacy increased by 0.3 ± 0.6. LCQ increased by 3.6 ± 3.0 points (95%CI 1.5 to 5.6). CS-VAS decreased by 18.8 ± 25.0 mm (95%CI -35.7 to -1.9), and 24-hour cough frequency decreased by 48% (95%CI -74% to +3%). CONCLUSIONS: CoughRetrain is a safe and feasible telehealth intervention for RCC developed through a transparent, patient-informed process. Preliminary findings align with behavioral cough literature. Larger controlled studies evaluating long-term efficacy are warranted.

LungVol. 204(1)
University Health Network (CA), Toronto Rehabilitation Institute (CA), Lupina Foundation (CA), Impact (CA), St. Joseph’s Healthcare Hamilton (CA), University of Aveiro (PT), McMaster University (CA)
Universidade de Aveiro
Quality Education
Openalex Percentile: Top 6%
Respiratory and Cough-Related Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.